Insider Title Company Date Price Return Shares Value
Ramachandra Sumant Non-Executive Director Lyell Immunopharma, Inc. (LYEL) 2025-03-21 $0.58 0.0% 200,000 $115,220
Return Profit / (loss) Cost
Total 0.0% $0 $115,220